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Abstract
We describe a 27-month-old girl with COG6 deficiency. She is the first
child of healthy consanguineous Moroccan parents. She presented at birth
with dysmorphic features including microcephaly, post-axial polydactyly, broad
palpebral fissures, retrognathia, and anal anteposition. The clinical phenotype
was further characterised by multiorgan involvement including mild psychomotor
retardation, and microcephaly, chronic inflammatory bowel disease, micronodular
liver cirrhosis, associated with life-threatening and recurrent infections due to
combined T- and B-cell dysfunction and neutrophil dysfunction.Mutation analysis
showed the patient to be homozygous for the c.G1646T mutation in the COG6
gene. She is the second reported patient with a deficiency of subunit 6 of the COG
complex. Although both patients are homozygous for the same mutation, they
present a markedly different clinical picture. Indeed immunodeficiency as well as
inflammatory bowel disease has not been described previously...
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Abstract We describe a 27-month-old girl with COG6
deficiency. She is the first child of healthy consanguineous
Moroccan parents. She presented at birth with dysmorphic
features including microcephaly, post-axial polydactyly,
broad palpebral fissures, retrognathia, and anal anteposi-
tion. The clinical phenotype was further characterised by
multiorgan involvement including mild psychomotor retar-
dation, and microcephaly, chronic inflammatory bowel
disease, micronodular liver cirrhosis, associated with life-
threatening and recurrent infections due to combined T- and
B-cell dysfunction and neutrophil dysfunction.
Mutation analysis showed the patient to be homozygous
for the c.G1646T mutation in the COG6 gene. She is the
second reported patient with a deficiency of subunit 6 of the
COG complex. Although both patients are homozygous
for the same mutation, they present a markedly different
clinical picture. Indeed immunodeficiency as well as
inflammatory bowel disease has not been described
previously in patients with any COG-CDG.
Introduction
Congenital disorders of glycosylation (CDG) are a group of
rare metabolic diseases caused by defects in the synthesis of
glycans and in the attachment of glycans to proteins and
lipids. The glycans on proteins are mostly N-linked or
O-linked. Two types of protein N-glycosylation disorders
can be distinguished: CDG-I (defects in the assembly of
N-glycans in the cytosol and the endoplasmic reticulum
(ER)) and CDG-II (defects in the processing and maturation
of N-glycans in the ER and subsequently in the Golgi
apparatus).
Patients with CDG form a rapidly growing group with a
broad spectrum of clinical manifestations (Jaeken and
Matthijs 2007; Gr€unewald et al. 2002; Jaeken 2010).
In 2004, Wu et al. described a new type of CDG due to a
defect in subunit 7 of the conserved oligomeric Golgi (COG)
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complex (Wu et al. 2004). Subsequently, defects in other
subunits (COG1, COG4, COG5, COG6, and COG8) have
been reported (Foulquier et al. 2006; Reynders et al. 2009;
Paesold-Burda et al. 2009; L€ubbenhusen et al. 2010;
Foulquier et al. 2007; Kranz et al. 2007). The COG is
a hetero-octameric peripheral Golgi protein complex
(COG1–COG8) and presents as a bi-lobed structure,
bridged through the COG1–COG8 interaction. This com-
plex appears to be required for the preservation of the
integrity of the Golgi, to facilitate transport of proteins
within the Golgi and for retrograde transport from the
Golgi to the ER. The exact mechanism by which the COG
complex influences the Golgi structure and function is
still unclear. However, it seems that COG defects affect
glycosylation through altered trafficking of glycosyltrans-
ferases (Smith and Lupashin 2008; Zeevaert et al. 2008).
We describe a second patient with COG6-CDG. She
presented with multi-system disease including dysmorphy
and neurological, hepato-intestinal, immunological and
renal involvement. The novel nomenclature will be used
in this report (Jaeken et al. 2008, 2009).
Case Report
We report a 27-month-old girl, born at 37 weeks of
gestation after an uncomplicated pregnancy. She is the first
child of healthy consanguineous Moroccan parents without
remarkable family history. Her birth weight and height were
respectively 2,860 g (1.1 SD) and 50 cm (0.1 SD). She
presented with dysmorphic features including microcephaly
(head circumference was 31.5 cm (2.5 SD)), a post-axial
polydactyly without syndactyly on the right hand, broad
palpebral fissures, retrognathia, and anal anteposition. She
showed a normal female karyotype.
During the first 3.5 months of life, she was hospitalised
four times because of recurrent infections, diarrhoea, and poor
weight gain. At the age of 8 months, the girl was admitted to
the intensive care unit of our hospital with respiratory failure
due to an interstitial pneumonia. A positive PCR for
Pneumocystis carinii and Rhinovirus was found in the
bronchoalveolar lavage. Laboratory tests revealed elevated
transaminases (up to a 20-fold increase, ASAT more than
ALAT) and slightly increased g-GT. PTT and aPTT were
normal and the child had no bleeding tendency. Serum lactate
and ammonia, plasma and urinary amino acids, organic acids,
and urinary oligosaccharides were normal. Infectious serol-
ogy (EBV, hepatitis, and toxoplasmosis), a sweat test, and
abdominal ultrasound were normal. Significant hypogamma-
globulinaemia (IgG 0.89 g/l, IgA < 0.06 g/l, and IgM
0.06 g/l, normal values for age, respectively, 5.4–13.3 g/l,
0.3–1.85 g/l, and 0.52–1.93 g/l) were found. Monthly
treatment with immunoglobulin was started. Further immu-
nologic studies confirmed the presence of a combined
immunodeficiency. In addition to antibody deficiency,
cellular immunity was impaired with a poor response to
mitogen (Phytohemagglutinin and CD3) and absence of
lymphocyte proliferation to antigen (Candidine and tetanus
toxin) after immunisation and despite recurrent skin and gut
colonisation with Candida albicans. Nevertheless, there was
no B or T lymphopenia and all the lymphocyte populations
were within the normal range for age. In addition to antibody
deficiency with T-cell dysfunction, granulocyte function
assays showed poor dihydrorhodamine reduction and a
reduced chemiluminescence (50% of controls). Chemotaxis,
adhesion molecules and phagocytosis assays were normal.
At the age of 10 months, nutritional support by total
parenteral nutrition followed by hyper-caloric feeding was
started because of poor weight gain, chronic diarrhoea,
and recurrent perianal fissures, but without significant
weight gain. Normal albuminemia made protein loosing
enteropathy unlikely. There was no proteinuria. The gastro-
and colonoscopy performed at that time were normal.
Because of the hepatomegaly, the hepatic cytolysis, and
failure to thrive, a liver biopsy was performed. This showed
signs of micronodular cirrhosis and minimal macrovesicular
steatosis with negative viral staining and no iron overload.
Additional metabolic investigations, including a screening
for CDG, were performed. The type 2 isoelectric focusing
(IEF) pattern of serum transferrin and the abnormal IEF
of serum apolipoprotein C-III in our patient pointed to a
CDG-II, affecting the biosynthesis of both N- and O-linked
glycans. Matrix-assisted laser desorption/ionisation-time of
flight (MALDI-TOF) analysis of serum transferrin glycans
showed mainly hyposialylation and a little hypogalactosyla-
tion (Fig. 1). Sequencing of the COG subunit genes revealed
a homozygous mutation (c.G1646T) in COG6 leading to
amino acid exchange p.G549V in the COG6 protein.
At the age of 2 years, severe failure to thrive with
microcephaly was still present (weight 7,700 g, 4.6 SD;
length 75 cm,3.1 SD; head circumference 45 cm,3.1 SD).
Neurological examination showed axial hypotonia associ-
ated with mild neurodevelopmental delay. She was able to
stand alone at the age of 16 months and said her first words at
2 years. One episode of febrile tonic-clonic seizures has been
observed. Ophthalmologic examination, EEG, and cerebral
MRI were normal.
At 24 months of age, a significant proximal tubulopathy
and bloody diarrhoea were noted for the first time. An
upper gastro-intestinal and lower endoscopy documented
the presence of deep serpiginous ulcerations in the sigmoid
and aphthous ulcers in the left part of the colon (Figs. 2
and 3). Biopsies showed an aspecific inflammatory infil-
trate of the mucosa. No granuloma or viral inclusions were
found on immunohisto-chemical staining. The findings
were compatible with inflammatory bowel disease. On
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Fig. 1 MALDI-TOF analysis of serum transferrin acidic glycans
showing a clear increase of the biantennary glycan with only 1 sialic
acid (mass 1932) and a small increase of the biantennary glycan with
only 1 sialic acid and 1 galactose (mass 1770) compared to a control.
Red diamonds sialic acid; yellow circles galactose; blue squares N-
acetylglucosamine; green circles mannose
Fig. 2 Presence of deep serpiginous ulcerations in the sigmoid before
treatment
Fig. 3 Aphthous ulceration present in the left part of the colon before
treatment
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parenteral nutrition followed by progressive enteral feeding
(Modulen IBD, Nestlé) and treatment with oral budesonide
(0.75 mg per day), the gastro-intestinal symptoms improved
and she started to gain some weight.
Discussion
Our patient has a clinical phenotype characterised by
multi-system involvement including chronic inflammatory
bowel disease, liver cirrhosis, mild psychomotor retarda-
tion and microcephaly, associated with life-threatening
and recurrent infections due to combined T and B
immunodeficiency and neutrophil dysfunction. She
presents with a homozygous mutation (c.G1646T) in the
COG6 gene and is the second reported patient with a
deficiency of COG6. The first patient described in 2010
by L€ubbenhusen et al., suffered from intractable focal
seizures, vomiting, and loss of consciousness due to
intracranial bleedings. Cholestasis and vitamin K defi-
ciency were found on metabolic investigation and consid-
ered, at least partly, as a cause for the intracranial
haemorrhage. The patient died at 5 weeks of age due to
brain oedema (L€ubbenhusen et al. 2010). Despite marked
differences in clinical presentation, both patients presented
with the same mutation c.G1646T. This mutation produces
instability of mRNA rather than a degradation of mutated
protein (L€ubbenhusen et al. 2010), indicating that individ-
ual factors could perhaps interfere with the degradation
speed of mRNA and contribute to the interindividual
phenotypical variation. Furthermore, MALDI-TOF analy-
sis of transferrin revealed in both children hyposialylation
associated with hypogalactosylation. Compared to our
patient, there was more hyposialylation than hypogalacto-
sylation in the first reported patient (Fig. 1). Another
possible explanation for the different clinical picture might
be the early death of the first patient before additional
symptoms could have developed. Also, another genetic
disease in our patient cannot be excluded taking into
account the consanguinity of the parents, possibly explain-
ing some unusual clinical features in particular the
immunodeficiency.
Since the first description of COG7 deficient patients
by Wu et al. in 2004, mutations in the genes encoding
subunits COG 1, 4–6, and 8 of the COG complex have
been identified. All these patients, including the present
one, show a combination of a type 2 serum transferrin IEF
pattern together with an abnormal serum apoC-III IEF
Table 1 Clinical phenotypes of patients with COG deficiency
COG-CDG
(number of
patients)
COG1–CDG (1) COG4-CDG (1) COG5-CDG (1) COG6-CDG (2) COG7-CDG (6) COG8-CDG (2)
Early death Early death
Dysmorphic
features
Present Mild Absent Present Absent Present Mild
Microcephaly Absent Present Absent Present Absent Severe Present
Failure to
thrive
Present No No Present – Present Present
Growth
retardation
Present Not Reported Absent Present – Present Present
Liver
involvement
Hepatosplenomegaly Elevated TA;
decreased
clotting factors
Absent Hepatomegaly;
elevated TA; normal
clotting factors;
cirrhosis
Bleeding;
mildly
elevated TA
Cholestasis; fibrotis;
normal coagulation
Bleeding and
thrombosis; TA
increased
inconsistently
Neurological
signs
Hypotonia Hypotonia;
epilepsia;
ataxia
Hypotonia;
ataxia
Hypotonia; febrile
seizures
Seizures Hypotonia; seizures;
neuropathy
Regression;
hypotonia;
seizures (once);
neuropathy;
ataxia
Psychomotor
retardation
Mild Mild Moderate Mild – Severe Moderate to
severe
Other Recurrent
infections
Combined
immunodeficiencies;
inflammatory bowel
disease
Hyperthermia; intestinal
pseudo-obstruction
Recurrent
infections;
PFAPA
Origin Portuguese Portuguese Iraqui Moroccan Turkish Moroccan and Tunisian Spanish
Publication Foulquier et al.
(2006)
Reynders et al.
(2009)
Paesold-Burda
et al. (2009)
This publication L€ubbenhusen
et al. (2010)
Wu et al. (2004),
Spaapen et al. (2005),
Morava et al. (2007),
Ng et al. (2007)
Foulquier et al.
(2007), Kranz
et al. (2007)
PFAPA: Periodic Fever Aphtous Stomatitis and Adenitis; TA: serum transaminases
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profile. The clinical phenotypes of these patients vary from
mild to severe with the COG7-CDG patients being the most
severely affected (Zeevaert et al. 2008). Our patient showed
some features that overlap with those of the previously
described COG deficient patients (Table 1). The phenotypic
differences correlate probably with differences in the
severity of the trafficking and glycosylation abnormalities
in patients’ fibroblasts (Reynders et al. 2009). A defect of
sialylation, galactosylation and demannosylation has been
found in COG7 deficient cells (the most severe form),
while in COG5-CDG (mild form) only the terminal
sialylation is affected (Reynders et al. 2009; Paesold-Burda
et al. 2009).
Despite recurrent infections reported in patients with
COG 4 and COG8 defects, no immunodeficiencies have
previously been described in COG-CDG. Nevertheless,
immunologic abnormalities, especially humoral deficien-
cies (hypogammaglobulinaemia associated with increased
or decreased B-lymphocytes), have already been described
in different types of CDG-1 like PMM2-CDG (CDG-Ia)
(Blank et al. 2006), ALG12-CDG (CDG-Ig); (Chantret
et al. 2002; Eklund et al. 2005; Zdebska et al. 2003) and
ALG1-CDG (CDG-Ik) (Kranz et al. 2004). In addition to
antibody deficiency, a diminished neutrophil chemotaxis
associated with normal expression of adhesion molecules,
has been found in PMM2-CDG. Our patient presents with
a combined B- and T-cell dysfunction despite normal B-
and T-cell counts for age. Moreover, we found a
diminished neutrophil chemiluminescence with normal
chemotaxis and expression of adhesion molecules. This
could reflect a defect in glycosylation of the gp91phox
subunit of the phagocyte NADPH-oxidase flavocyto-
chrome b 558, involved in the production of free radicals
in neutrophils (Parkos et al. 1987). Further studies are
needed.
Protein loosing enteropathy coupled with intractable
diarrhoea is a leading sign in MPI-CDG, ALG6-CDG and,
less, in PMM2-CDG and may be due to altered mucosal
integrity because of defects in membranous glycoproteins.
The diagnosis was based on an increased a-1-antitrypsin in
the stools or low serum albumin without proteinuria (Damen
et al. 2004; Kelly et al. 2001; Mention et al. 2001). In our
patient, we found mucosal lesions in the left part of the colon
identical to those found in inflammatory bowel disease and
responding to a treatment with oral steroids and enteral
nutrition. There were no signs of protein loosing enteropathy.
This has never been reported before in patients with COG
defects and could be related to a functional defect in the
immune system. Further studies are needed to characterise
the immunological processes involved in the pathogenesis of
the digestive lesions.
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